Accessibility Menu
 
CelLBxHealth Plc logo

CelLBxHealth Plc

(LSE) AGL

Current PriceN/A
Market CapN/A
Since IPO (2004)-99%
5 Year-99%
1 Year-90%
1 Month+0%

CelLBxHealth Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$2.62M

Net Income (TTM)

$15.78M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

AGL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CelLBxHealth Plc

Industry

Healthcare Equipment and Supplies

Employees

119

CEO

Andrew D. W. Newland

Headquarters

Guildford, GU2 7AF, GB

AGL Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.78M

Operating Income

$15.10M

EBITDA

$13.02M

Operating Cash Flow

$13.45M

Capital Expenditure

$444.00K

Free Cash Flow

$13.89M

Cash & ST Invst.

$10.43M

Total Debt

$4.21M

CelLBxHealth Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$398.00K

-23.0%

Gross Profit

$233.00K

-23.7%

Gross Margin

58.54%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

150

N/A

Net Income

$4.63M

-20.2%

EBITDA

$4.62M

-18.6%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$1.60M

-88.3%

Accounts Receivable

$1.68M

-12.5%

Inventory

$1.57M

-10.7%

Long Term Debt

$2.81M

-20.0%

Short Term Debt

$1.71M

+20.9%

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

$2.34M

+32.2%

Operating Cash Flow

$2.30M

+32.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GDR.LGenedrive Plc
$0.95+2.70%
FUM.LFutura Medical plc
$0.75-10.77%
RUA.LRUA Life Sciences plc
$19.50-4.88%
PRM.LProteome Sciences plc
$1.68+12.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About AGL

What is the current price of CelLBxHealth Plc?

CelLBxHealth Plc is trading at N/A per share.

What is the 52-week range for CelLBxHealth Plc?

Over the past 52 weeks, CelLBxHealth Plc has traded between N/A and N/A.

How much debt does CelLBxHealth Plc have?

As of the most recent reporting period, CelLBxHealth Plc reported total debt of $4.21M.

How much cash does CelLBxHealth Plc have on hand?

CelLBxHealth Plc reported $10.43M in cash and cash equivalents in its most recent financial results.

What is CelLBxHealth Plc’s dividend yield?

CelLBxHealth Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.